机构

• 上海药物研究所 [11]

采集方式

• OAI收割 [11]

内容类型

• 期刊论文 [11]

发表日期

• 2023 [1]
• 2022 [2]
• 2021 [3]
• 2020 [1]
• 2019 [1]
• 2018 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Discovery of HCD3514 as a potent EGFR inhibitor against C797S mutation in vitro and in vivo 期刊论文  OAI收割 JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 1, 页码: 152-162 作者:  Lai, Mengzhen;  Zhang, Tao;  Chen, Hao;  Song, Peiran;  Tong, Linjiang   |  收藏  |  浏览/下载：80/0  |  提交时间：2023/04/10 fourth-generation EGFR inhibitor  EGFRC797S mutation  NSCLC  drug resistance  small molecular inhibitor   Structure-Based of a Series of NSD2-PWWP1 Inhibitors 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 13, 页码: 9459-9477 作者:     |  收藏  |  浏览/下载：9/0  |  提交时间：2024/03/21 Withaphysalins from Medicinal and Edible Physalis minima and Their Anti-inflammatory Activities 期刊论文  OAI收割 JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2022, 卷号: 70, 期号: 18, 页码: 5595-5609 作者:  Hu, Bintao;  Li, Han;  Tang, Chunping;  Ke, Chang-Qiang;  Geng, Meiyu   |  收藏  |  浏览/下载：31/0  |  提交时间：2022/08/16 Physalis minima  withaphysalin  14?-OH  anti-inflammatory  NF-?B   LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo 期刊论文  OAI收割 CANCER SCIENCE, 2021, 页码: 12 作者:  Liu, Yingqiang;  Lai, Mengzhen;  Li, Shan;  Wang, Yanan;  Feng, Fang   |  收藏  |  浏览/下载：87/0  |  提交时间：2022/01/18 C797S  epidermal growth factor receptor  fourth-generation EGFR TKI  non-small cell lung cancer  osimertinib resistance   Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020) 期刊论文  OAI收割 MOLECULAR CANCER, 2021, 卷号: 20, 期号: 1, 页码: 1 作者:  Zhang, Tao;  Qu, Rong;  Chan, Shingpan;  Lai, Mengzhen;  Tong, Linjiang   |  收藏  |  浏览/下载：87/0  |  提交时间：2021/11/04 Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文  OAI收割 Molecular Cancer, 2021, 卷号: 20, 期号: 1 作者:     |  收藏  |  浏览/下载：61/0  |  提交时间：2021/11/04 Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance 期刊论文  OAI收割 MOLECULAR CANCER, 2020, 卷号: 19, 期号: 1, 页码: 15 作者:     |  收藏  |  浏览/下载：79/0  |  提交时间：2020/07/01 Non-small cell lung cancer (NSCLC)  EGFR T790M  Small-molecule inhibitor  Drug resistance  Ack1   Discovery of a novel third generation EGFR TKI and identification of its potential mechanism of resistance 期刊论文  OAI收割 CANCER RESEARCH, 2019, 卷号: 79, 期号: 13, 页码: 2 作者:  Zhang, Tao;  Qu, Rong;  Chen, Chengbin;  Tong, Linjiang;  Feng, Fang   |  收藏  |  浏览/下载：14/0  |  提交时间：2020/07/01 identificationofcompoundd2923asanovelantitumoragenttargetingcsf1r 期刊论文  OAI收割 actapharmacologicasinica, 2018, 卷号: 039, 期号: 011, 页码: 1768 作者:  Liu Yingqiang;  Wang Yanan;  Lu Xiaoyun;  Tong Linjiang;  Li Yan   |  收藏  |  浏览/下载：17/0  |  提交时间：2020/07/01 肿瘤组织  代理人  apoptosis  生长抑制率  复合  指向  鉴定  巨噬细胞   C5-substituted pyrido[2,3-d]pyrimidin-7-ones as highly specific kinase inhibitors targeting the clinical resistance-related EGFR(T790M) mutant 期刊论文  OAI收割 MEDCHEMCOMM, 2015, 卷号: 6, 期号: 9, 页码: 1693-1697 作者:  Xu, Tianfeng;  Peng, Ting;  Ren, Xiaomei;  Zhang, Lianwen;  Yu, Lei   |  收藏  |  浏览/下载：36/0  |  提交时间：2019/01/08